medical-aesthetics
(5)
Robert Bestwick Built a Career Between Two Kinds of Attention
From rural Chilean businesses to a Vancouver classroom and an established aesthetics brand, Robert Bestwick’s career is a study in translating attention into useful action.
Samuel Schloss
Samuel Schloss is the co-founder and CEO of Annie Aesthetic, a medical-aesthetics platform incubated by Tucker's Farm Corporation that consolidates leading U.S. medspas under one operating umbrella. Since launching in May 2022 with roughly $30 million in seed capital, the company has grown to twelve brands and a $65 million revenue run-rate, closing a Series B in 2025 led by InterAlpen Partners. Schloss came from investment banking and private equity, including Reverence Capital Partners.
Todd Watts
Todd Watts is the co-founder and CEO of PatientFi, an Irvine, California fintech that lets patients pay for elective and out-of-pocket healthcare in monthly installments at the point of care. Since starting the company in 2017, he has built a platform that has helped roughly 320,000 patients qualify for more than $3 billion in care across aesthetics, fertility, dentistry, ophthalmology and audiology, reaching a $140 million annual revenue run rate and 130 employees. A former J.P. Morgan investment banker with a Yale MBA, Watts was named an EY Entrepreneur Of The Year 2024 Pacific Southwest winner.
Chris Boudreaux
Chris Boudreaux is a fintech professional and co-founder associated with Cherry (withcherry.com), a San Francisco-based healthcare financing platform trusted by over 60,000 medical providers across the United States. Cherry enables patients to access flexible, interest-free payment plans for elective medical procedures - dental, plastic surgery, medspas, and veterinary care - while giving providers same-day upfront payment. Based in Chattanooga, Tennessee, Boudreaux operates at the intersection of financial technology and healthcare access, helping expand Cherry's reach across the healthcare provider ecosystem.
Felix Steinmeyer
Felix Steinmeyer is the CEO and Co-Founder of Cherry, the leading buy-now-pay-later platform built specifically for healthcare and wellness providers. A Stanford MBA with dual master's degrees, he previously co-founded and sold Mason Finance before turning his attention to the underserved gap between patients who need care and their ability to pay for it. Under his leadership, Cherry has grown to serve 60,000+ providers, raised a Series B of $44M in 2022, and in April 2025 achieved a valuation exceeding $2 billion with a Series C round - making it one of the most significant vertical BNPL players in healthcare.